Papers - YOSHINO HIRONORI
-
Phase-separated super-enhancers confer an innate radioresistance on genomic DNA.
Matsumoto K, Ikliptikawati DK, Makiyama K, Mochizuki K, Tobita M, Kobayashi I, Voon DC, Lim K, Ogawa K, Kashiwakura I, Suzuki HI, Yoshino H, Wong RW, Hazawa M
Journal of radiation research 2024.6
-
Involvement of retinoic acid‑inducible gene‑I in radiation‑induced senescence of human umbilical vein endothelial cells
Fuki Sasaki, Hironori Yoshino, Ayumu Kusuhara, Kota Sato, Eichi Tsuruga
Biomedical Reports 20 ( 4 ) 2024.3
-
Generality assessment of a model considering heterogeneous cancer cells for predicting tumor control probability for stereotactic body radiotherapy against non-small cell lung cancer
Ryo Saga, Yusuke Matsuya, Hideki Obara, Fumio Komai, Hironori Yoshino, Masahiko Aoki, Yoichiro Hosokawa
Advances in Radiation Oncology 101437 - 101437 2024.1
-
Super-enhancer trapping by the nuclear pore via intrinsically disordered regions of proteins in squamous cell carcinoma cells.
Hazawa M, Ikliptikawati DK, Iwashima Y, Lin DC, Jiang Y, Qiu Y, Makiyama K, Matsumoto K, Kobayashi A, Nishide G, Keesiang L, Yoshino H, Minamoto T, Suzuki T, Kobayashi I, Meguro-Horike M, Jiang YY, Nishiuchi T, Konno H, Koeffler HP, Hosomichi K, Tajima A, Horike SI, Wong RW.
Cell Chemical Biology 2023.12
-
Prediction of hub genes and key pathways associated with the radiation response of human hematopoietic stem/progenitor cells using integrated bioinformatics methods.
Sato Y, Yoshino H, Ishikawa J, Monzen S, Yamaguchi M, Kashiwakura I.
13 ( 1 ) 10762 2023.7
-
ΔNp63 Regulates Radioresistance in Human Head and Neck Squamous Carcinoma Cells
Sato K, Yoshino H, Sato Y, Nakano M, Tsuruga E.
Current issues in molecular biology 45 ( 8 ) 6262 - 6271 2023.7
-
DAP3-mediated cell cycle regulation and its association with radioresistance in human lung adenocarcinoma cell lines
Yoshiaki Sato, Hironori Yoshino, Kota Sato, Ikuo Kashiwakura, Eichi Tsuruga
2023.5
-
Cytotoxic activity of unique synthesized five-membered heterocyclic compounds coordinated with tiopronin monovalent
Naoyuki Sanoa, Hironori Yoshinob, Yoshiaki Sato, Hideo Honma, Christopher E. J. Cordonierc, Ikuo Kashiwakura
2023.5
-
Translational study for stereotactic body radiotherapy against non-small cell lung cancer, including oligometastases, considering cancer stem-like cells enable predicting clinical outcome from in vitro data
Ryo Saga, Yusuke Matsuya, Hikari Sato, Kazuki Hasegawa, Hideki Obara, Fumio Komai, Hironori Yoshino, Masahiko Aoki, Yoichiro Hosokawa
2023.4
-
cGAS Regulates the Radioresistance of Human Head and Neck Squamous Cell Carcinoma Cells.
Taichi Nyui, Hironori Yoshino, Tetsuya Nunota, Yoshiaki Sato, Eichi Tsuruga
Cells 11 ( 9 ) 2022.4
-
Effects and Related Mechanisms of the Senolytic Agent ABT-263 on the Survival of Irradiated A549 and Ca9-22 Cancer Cells.
Kota Sato, Soichiro Iwasaki, Hironori Yoshino
International journal of molecular sciences 22 ( 24 ) 2021.12
-
The Effect of High-Dose-Rate Pulsed Radiation on the Survival of Clinically Relevant Radioresistant Cells.
Shingo Terashima, Hironori Yoshino, Yoshikazu Kuwahara, Hiro Sakuraba, Yoichiro Hosokawa
Life (Basel, Switzerland) 11 ( 12 ) 2021.11
-
Discovery of a Novel Small-Molecule Interleukin-6 Inhibitor through Virtual Screening Using Artificial Intelligence.
Yoshiaki Sato, Ikuo Kashiwakura, Masaru Yamaguchi, Hironori Yoshino, Takeshi Tanaka, Ken Ikeda, Zhengmao Ye, Hirotsugu Komatsu, Takao Matsuzaki, Masato Hosoda
Medicinal chemistry (Shariqah (United Arab Emirates)) 2021.11
-
Cytotoxic activity of a unique monomeric heterogeneous two-coordinate ligand monovalent gold complex with tiopronin and a heterocyclic mercapto-tetrazole compound.
Naoyuki Sano, Hironori Yoshino, Yoshiaki Sato, Hideo Honma, Christopher E J Cordonier, Ikuo Kashiwakura
Current medicinal chemistry 2021.10
-
Not Only Hypoxia- but Radiation-Induced Epithelial-Mesenchymal Transition Is Modulated by Hypoxia-Inducible Factor 1 in A549 Lung Cancer Cells.
Sato M, Hirose K, Ichise K, Yoshino H, Harada T, Hatayama Y, Kawaguchi H, Tanaka M, Fujioka I, Takai Y, Aoki M
Folia biologica 67 ( 2 ) 62 - 69 2021.10
-
KPNB1 Inhibitor Importazole Reduces Ionizing Radiation-Increased Cell Surface PD-L1 Expression by Modulating Expression and Nuclear Import of IRF1.
Hironori Yoshino, Yoshiaki Sato, Manabu Nakano
Current issues in molecular biology 43 ( 1 ) 153 - 162 2021.5
-
Matrix Metalloproteinase-2 Activated by Ultraviolet-B Degrades Human Ciliary Zonules In Vitro
Yuki Shiroto, Ryo Saga, Hironori Yoshino, Yoichiro Hosokawa, Keitaro Isokawa, Eichi Tsuruga
Acta histochemica et cytochemica 54 ( 1 ) 1 - 9 2021.2
-
DAP3 Is Involved in Modulation of Cellular Radiation Response by RIG-I-Like Receptor Agonist in Human Lung Adenocarcinoma Cells.
Yoshiaki Sato, Hironori Yoshino, Ikuo Kashiwakura, Eichi Tsuruga
International journal of molecular sciences 22 ( 1 ) 2021.1
-
Karyopherin-β1 Regulates Radioresistance and Radiation-Increased Programmed Death-Ligand 1 Expression in Human Head and Neck Squamous Cell Carcinoma Cell Lines.
Masaharu Hazawa, Hironori Yoshino, Yuta Nakagawa, Reina Shimizume, Keisuke Nitta, Yoshiaki Sato, Mariko Sato, Richard W Wong, Ikuo Kashiwakura
Cancers 12 ( 4 ) 2020.4
-
Disease-specific alteration of karyopherin-α subtype establishes feed-forward oncogenic signaling in head and neck squamous cell carcinoma.
Masaharu Hazawa, Kie Sakai, Akiko Kobayashi, Hironori Yoshino, Yoshihiro Iga, Yuki Iwashima, Kee Sing Lim, Dominic Chih-Cheng Voon, Yan-Yi Jiang, Shin-Ichi Horike, De-Chen Lin, Richard W Wong
Oncogene 39 ( 10 ) 2212 - 2223 2020.3